Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial

NCT06662253 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism (VTE)
Trauma Related Injuries

Interventions

DRUG: Anti-Xa Guided Dosing of Low Molecular Weight Heparin
DRUG: Standard of Care Dosing

Sponsor

Alexandre Tran